Search

Aims: The aim of this study was to investigate the effects of spironolactone on left ventricular (LV) remodeling in patients with preserved LV function following acute myocardial infarction (AMI)., Methods and Results: Successfully revascularized patients (n = 186) with acute ST elevation MI (STEMI) were included in the study. Patients were randomly divided into three groups, each of which was administered a different dose of spironolactone (12.5, 25 mg, or none). Echocardiography was performed within the first 3 days and at 6 months after MI. Echocardiography control was performed on 160 patients at a 6-month follow-up. The median left ventricular ejection fraction (LVEF) increased significantly in all groups, but no significant difference was observed between groups (P = 0.13). At the end of the sixth month, the myocardial performance index (MPI) had improved in each of the three groups, but no significant difference was found between groups (F = 2.00, P = 0.15). The mean LV peak systolic velocities (Sm ) increased only in the control group during the follow-up period, but there is no significant difference between groups (F = 1.79, P = 0.18). The left ventricular end-systolic volume index (LVESVI) and the left ventricular end-diastolic volume index (LVEDVI) did not change significantly compared with the basal values between groups (F = 0.05, P = 0.81 and F = 1.03, P = 0.31, respectively)., Conclusion: In conclusion, spironolactone dosages of up to 25 mg do not augment optimal medical treatment for LV remodeling in patients with preserved cardiac functions after AMI., (© 2012 John Wiley & Sons Ltd.)

Ingestion of acid-containing household products, either accidentally or as a suicide attempt, is a common form of intoxication. A clear and odorless liquid, hydrogen peroxide is an oxidizing agent found in most households and many industrial environments. Cardiovascular manifestations of hydrogen peroxide ingestion are extremely rare. Here we report a 60 year-old woman with acute inferolateral myocardial infarction (MI) after hydrogen peroxide ingestion, who had no history of coronary artery disease. Physicians dealing with hydrogen peroxide ingestion in the emergency department should be aware of the probability of MI and obtain an electrocardiogram, even if the patient has no cardiac complaint.

Data related to the incidence and clinical outcome of acute myocardial infarction (AMI) in patients with preexisting coronary artery ectasia (CAE) are limited. We assessed whether infarct-related artery ectasia (EIRA) indicates an untoward clinical outcome in patients with AMI undergoing primary percutaneous coronary intervention (pPCI). Consecutive patients (n = 643) who presented with AMI and were treated with pPCI were analyzed retrospectively; 31 patients (4.8%) had EIRA. Patients who had EIRA were significantly younger and had higher incidence of hypertension, previous stroke, smoking, inferior wall AMI, and Killip score >1. Infarct-related artery ectasia was more frequent in the right coronary artery (RCA). Impaired epicardial arterial flow, thrombus burden score of infarct-related artery (IRA), impaired Thrombolysis in Myocardial Infarction (TIMI) Myocardial Perfusion Grade, and distal embolization were significantly higher whereas ST-segment resolution and collateral vascular development were significantly lower in patients with EIRA. Infarct-related artery ectasia was an independent predictor of adverse outcome (odds ratio: 0.197; 95% confidence interval [CI]: 0.062-0.633; P = .006).

Objectives: In this study, we sought to examine the effect of glucose-insulin-potassium (GIK) treatment on oxidative stress in patients with acute coronary syndromes (ACSs) undergoing percutaneous coronary interventions (PCIs)., Methods: Patients with ACSs who had been electively treated with a stent implantation into the culprit vessel were included in this study. Patients were divided into two groups and were randomly administered either the GIK treatment (GIK group; n=28) or isotonic NaCl (control group; n=19) infusion during PCI. Blood samples from the coronary artery ostium (CO) were collected through the femoral artery and from the coronary sinus (CS) through the femoral vein, before and immediately after PCI. Superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities were measured., Results: A total of 47 patients were included in the study. SOD, CAT, and GSH-Px activities, whether in the CO or the CS, were similar in both the GIK and control groups before the intervention (P>0.05). In the control group, SOD (in both the CO and the CS), CAT (in the CS), and GSH-Px (in the CS) activities were higher compared with baseline values (P<0.05). Such increases were, however, not seen in the GIK group (P>0.05). Although the CS-CO activity differences (venous-arterial) of SOD, CAT, and GSH-Px, which are parameters of myocardial reactive antioxidant enzyme production, were increased in the control group, there was no increase in the GIK group., Conclusions: In patients with ACSs, reactive local enzyme activity increases for the scavenging to myocardial-free radicals during PCI. Administration of a solution of GIK as a metabolic support agent might prevent oxidative stress in the myocardial level, in these patients.

Objective: To present a case of myocardial infarction due to Behçet's syndrome., Clinical Presentation and Intervention: A 27-year-old man who was known to have Behçet's syndrome for 1 year presented with retrosternal fluctuating chest pain, which radiated to the epigastrium 5 h prior to admission. Coronary angiography showed total occlusion of the left anterior descending coronary artery, which was successfully treated with coronary stent implantation., Conclusion: This case shows that patients with Behçet's syndrome who had acute chest pain should be thoroughly examined for any signs of acute myocardial infarction., ((c) 2008 S. Karger AG, Basel.)

Background: Although there have been several association studies of angiotensin II type 1 receptor (AT1R, A/C1166) gene polymorphism in clinical endpoints such as myocardial infarction (MI), hypertension, aortic stiffness, and left ventricular mass, the relationship between AT1R polymorphism and biventricular function in acute anterior MI has not been studied before., Methods and Results: The study group comprised 132 consecutive patients who were admitted to the coronary care unit with their first acute anterior MI. Systolic and diastolic diameters, volumes, inflow properties, ejection fraction and myocardial performance index of both ventricles were measured. AT1R polymorphism was determined using polymerase chain reaction amplification. Based on A/C1166 polymorphism of AT1R, the patients were classified into 3 groups: group 1, A/A (n=91) genotype, group 2 A/C (n=28), and group 3 C/C (n=13) genotype. When the left ventricular and right ventricular echocardiographic functions were compared, all parameters of the 3 groups were found to be similar. No difference was detected in either the genotype distribution or allele frequencies between the patients and the controls for AT1R., Conclusions: The results suggest that A/C1166 polymorphism of AT1R did not influence the risk of either acute MI or biventricular function after anterior MI.

Objective: The main aim of the study was, to estimate the impact of perfusion defects including significantly depleted areas of varying size on gated perfusion SPECT (GPS) determined ejection fraction (EF) measurements in comparison to radionuclide ventriculography (RVG). A secondary objective was the evaluation of the GPS-RVG agreement of EF in patients with normal and deteriorated left ventricular function, separately., Methods: Fifty-nine patients having perfusion defects including at least one segment with no visible tracer uptake in rest myocardial GPS related to myocardial infarction (older than 15 days) were studied. Myocardial perfusion was visually analyzed using a 17 segment-model, on a five-point (0-4) grading system in which Grade-4 (0-9% maximal uptake) represents cold defects. The patients with >or=4 adjacent, with 2-3 adjacent and with 1 single cold segments were named as Group1(GR1), Group2(GR2) and Group3(GR3), respectively. Secondly, the patients were re-grouped according to RVG-EF values. (Group A: patients with EF<50%; Group B: patients with EF>or=50%). In each group, the GPS-EFs were compared with RVG performed within one week and also the variations of GPS-RVG EF differences among the groups were statistically analyzed., Results: In overall (r=0.86) and in each subgroup, EFs obtained by GPS were well correlated with RVG. However, in overall (difference mean EF% [dEF%]=4.6+/-6.7, p<0.001) as well as in subgroup evaluation, GPS significantly (p<0.005) underestimated EF. There was no statistically significant difference in GPS-RVG EF variations between GR1, GR2 and GR3 (p>0.05). The RVG-mean differences and RVG-correlation coefficients calculated for GR1,GR2 and GR3 were dEF%=3.1+/-4.6, r=0.85; dEF%=3.7+/-6.03, r=0.80 and dEF%=6.2+/-8.03, r=0.79, respectively. Mean dEF% was statistically higher in group-B than group-A (mean difference of dEF%=4,2, p<0.05). In group-A, GPS-EF values were better agreed with RVG (dEF%=3.34, r=0.75) than in group-B (dEF%=7.52, r=0.53)., Conclusion: The stability of the calculation algorithm of QGS in EF calculation of patients with large depleted infarct areas could be confirmed. The agreement of GPS determined EF is higher in patients having myocardial integrity loss and left ventricular dysfunction.

The agreement in left ventricular (LV) ejection fraction (EF) determination between the gated perfusion SPECT (GPS) and radionuclide ventriculography (RVG) methods has been reported to show a systematic reduction with increasing EF values. In some reports, this EF difference exceeds 5%, indicating a critical underestimation rate by GPS in terms of clinical reliability. Although the accuracy of endocardial edge detection by means of GPS proves to be reliable, even in patients with large perfusion defects, the accuracy of EF calculation seems to depend on the level of individual EF values. Our objective was to investigate the RVG-GPS agreement in EF determination specifically in patients with myocardial infarction (MI) having perfusion defects including extremely depleted areas and LV dysfunction. Our patients had a EF<50%, a population in which the best agreement values between the above two methods should be found according to the literature. The idea was to test the accuracy of QGS algorithm in the presence of cold perfusion defects and a low probability of EF level influence. Thirty-six patients (26 males; 61.8+/-9.1 y and 10 female; 64.1+/-10.7 y) with MI older than two weeks, having perfusion defects, including all regions of varying size with no visible tracer uptake in rest GPS and RVG-EF<50% were included in the study. Rest-GPS was performed by injecting iv 925 MBq 99mTc-sestamibi (8-time bins) using a dual-headed gamma camera and rest-RVG was performed within the following three days by injecting iv 740 MBq 99mTc-pertechnetate-pyrophosphate (24 time bins). Myocardial perfusion was visually analyzed on a 17 segment-model and summed rest perfusion scores (SRS) were determined. The cold defect number (CDN) was calculated by selecting the myocardial segments with 0%-9% of maximal tracer uptake (grade 4) to identify the extent of the depleted tissue in each patient. The patients with (3)4 adjacent myocardial segments with grade 4 perfusion were considered as having large cold defects (Group 1: GR1). Patients with two or three CDN constituted the Group 2 (GR2; medium cold defects) and those with only one CDN constituted Group 3 (GR3; small cold defects). Hereafter, the relative weight of cold perfusion defects (CD%) and infarcted segments (IS%) were calculated for all patients and subgroups. Of 36 patients studied, 14 patients (39%, GR1) had large cold defects. Eleven patients (30.5%, GR2) had moderate and 11 (30.5%, GR3) had small cold defects. The overall mean value of CDN was 3.03+/-1.96 (1-9). Mean EF values in RVG and GPS among Groups 1, 2 and 3 were 28.78%+/-6.32%, 38.46%+/-6.43%, 38.73%+/-8.55% and 27.0%+/-6.93%, 37.82%+/-8.80%, 33.27%+/-11.65%, respectively. The percentage of patients showing an EF difference pound 5% between RVG and GPS in Groups 1, 2 and 3 were 93%, 73% and 27%, respectively. The CD% and IS% were 19+/-12, 30+/-7, 14+/-3, 6 and 52+/-20, 61+/-18, 50+/-17, 42+/-23 in overall, GR1, GR2 and GR3, respectively. It is concluded that: the negligible underestimation of EF in GR1 by GPS compared to RVG confirms the stability of the geometric modeling algorithm of QGS in this particular patient sub-group. Although the agreement results in patients with smaller defects were probably influenced through the realization of RVG and GPS studies performed on different days, it seems to be rational to set the threshold of RVG-GPS agreement dependency on EF levels in patients with myocardial infarction lower than 50%.

Sumatriptan is widely used in the treatment of acute attacks of cluster headache. It is a serotonin-1 (5HT-1) agonist. Several studies have reported an association between sumatriptan use and myocardial infarction, possibly due to the generalized vasoconstrictive nature of this agent. We report a 16-year-old male patient presenting with acute inferior myocardial infarction after sumatriptan use without any known risk factors of coronary artery disease.

The aim of the study was to compare lipoprotein(a) [Lp(a)] levels in patients with cTroponin-I (cTn-I)-positive or -negative unstable angina and to investigate their relationship with atherothrombosis. A total of 202 consecutive patients were enrolled in the study. Lp(a), fibrinogen, plasminogen, PAI-1 and t-PA levels were measured and C-reactive protein (CRP) assays were performed on admission for all patients, and venous blood samples were drawn 12 and 24 h later for cTn-I measurements. The patients were divided into cTn-I-negative (cTn-I < 1 ng/ml) and -positive (cTn-I > or = 1 ng/ml) unstable angina groups. Lp(a) levels of the cTn-I-positive patients were higher than those of the cTn-I-negative patients (52.9 +/- 6.0 and 15.7 +/- 2.5 mg/dl, p < 0.0001). There was a positive correlation between Lp(a) and cTn-I levels (r = 0.692; p = 0.0001). Increase in coagulation activity and impairment in fibrinolytic activity were significant in the cTn-I-positive patients. Elevated Lp(a) levels may have a role in the development of myocardial damage in patients with unstable angina.

Background: Atrial fibrillation (AF) is a common arrhythmia occurring in about 10-20% of patients with acute myocardial infarction (AMI). P-wave dispersion (PWd) and P-wave duration (PWD) have been used to evaluate the discontinuous propagation of sinus impulse and the prolongation of atrial conduction time, respectively. This study was conducted to compare the effects of reperfusion either by thrombolytic therapy or primary angioplasty on P-wave duration and dispersion in patients with acute anterior wall myocardial infarction., Methods: We have evaluated 72 consecutive patients retrospectively (24 women, 48 men; aged 58 +/- 12 years) experiencing acute anterior wall myocardial infarction (AMI) for the first time. Patients were grouped according to the reperfusion therapy received (primary angioplasty (PTCA) versus thrombolytic therapy). Left atrial diameter and left ventricular ejection fraction (LVEF) were determined by echocardiography in all patients. Electrocardiography was recorded from all patients on admission and every day during hospitalization. Maximum (P max) and minimum (P min) P-wave durations and P-wave dispersions were calculated before and after the treatment., Results: There were not any significant differences between the groups regarding age, gender, left ventricular ejection fraction, left atrial diameter and volume, cardiovascular risk factors, and duration from symptom onset to treatment. P-wave dispersions and P-wave durations were significantly decreased after PTCA [Mean P max was 113 +/- 11 ms before and 95 +/- 17 ms after the treatment (P = 0.007)]. Mean PWd was 46 +/- 12 ms before and 29 +/- 10 ms after the treatment (P = 0.001). Also, P max and PWd were significantly lower in PTCA group (for P max 97 +/- 22 ms vs 114 +/- 16 ms and for PWd 31 +/- 13 ms vs 55 +/- 5 ms, respectively)., Conclusions: Primary angioplasty reduces the incidence of AF by decreasing P max and P-wave dispersion.

Background and Objectives: The aim of the present study is to assess the safety and efficacy of performing primary angioplasty in a center without on-site surgical back-up, and compare the data with the literature., Methods: Seventy-eight consecutive primary angioplasty procedures, performed in our center from January 2001 to February 2003, were followed prospectively. Clinical and demographic characteristics of the patients, procedural success, early and late outcomes of the patients were taken into account. The safety of angioplasty was assessed by the analysis of in-hospital complications (death, urgent need for repeat revascularization, AMI with or without ST-elevation and stroke). The angioplasty procedures were considered effective when the post-procedural residual stenosis did not exceed 50% with the distal Thrombolysis in Myocardial Infarction (TIMI) grade III flow., Results: The device success rate was 92.3%. Angiographic success rate was 88.8%. In hospital mortality rate was 4.1%. These patients were admitted with cardiogenic shock; 1 died during the procedure and the other 2 died during hospital follow-up. One patient died suddenly and another developed acute MI during the 6-month follow-up period. No patients developed stroke or were referred for urgent surgery. Four patients (5.5%) underwent repeat angioplasty during follow-up., Conclusions: Primary angioplasty can be safely performed in centers without on-site surgery. The efficacy and safety requirements of angioplasty, performed in a center without on-site surgical back-up using a mobile catheterization facility were similar to the data obtained from the literature.